Literature DB >> 8959898

Botulinum toxin--a possible new treatment for axillary hyperhidrosis.

K O Bushara1, D M Park, J C Jones, H S Schutta.   

Abstract

The inhibitory action of botulinum toxin is not limited to the neuromuscular junction. The toxin also blocks the autonomic cholinergic fibres, including the sympathetic fibres to sweat glands. We have previously demonstrated that the toxin produces localized anhidrosis. To determine the dosage, pattern and duration of the anhidrotic effect of botulinum toxin and to test the efficacy of axillary injections, we further studied seven healthy volunteers. Two individuals had subcutaneous injections of botulinum toxin (20 mouse units, Dysport-Porton Products) in the dorsum of the hand. Five healthy volunteers had 15-50U of botulinum toxin A (Botox) injected in one axilla. A circular area of complete anhidrosis on the dorsum of the hand was evident on day 2 and persisted for 11 months. By day 3, two of the axillae (injected with 50 U each) were totally dry and in one (injected with 30 U) the sweating was substantially reduced. The effect persisted for 6-8 months before wearing off. No effect was appreciated in two axillae (injected with 15 and 20 U). No significant side-effects were encountered. Subcutaneous injections of botulinum toxin causes chemodenervation of the sweat glands. In normal individuals axillary sweating can be abolished by 50 U of botulinum toxin A (Botox). The results offer a possible novel treatment for severe cases of axillary hyperhidrosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8959898     DOI: 10.1111/j.1365-2230.1996.tb00093.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  19 in total

1.  Treating hyperhidrosis. Surgery and botulinum toxin are treatments of choice in severe cases.

Authors:  J Collin; P Whatling
Journal:  BMJ       Date:  2000-05-06

2.  Aluminum chloride hexahydrate in a salicylic Acid gel: a novel topical agent for hyperhidrosis with decreased irritation.

Authors:  Heather Woolery-Lloyd; Whitney Valins
Journal:  J Clin Aesthet Dermatol       Date:  2009-06

3.  Is active sweating during heat acclimation required for improvements in peripheral sweat gland function?

Authors:  Michael J Buono; Travis R Numan; Ryan M Claros; Stephanie K Brodine; Fred W Kolkhorst
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-05       Impact factor: 3.619

4.  The role of clostridium botulinum: a neurotoxin in clinical dermatology.

Authors:  S L Matarasso
Journal:  West J Med       Date:  1998-10

5.  Personal Technique of Microinfiltration With Botulin Toxin: The SINB Technique (Superficial Injection Needling Botulinum).

Authors:  Francesco Calvani; Stefania Santini; Emanuele Bartoletti; Alessandra Alhadeff
Journal:  Plast Surg (Oakv)       Date:  2018-10-11       Impact factor: 0.947

6.  Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system.

Authors:  Dirk Dressler
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

7.  Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.

Authors:  M Naumann; N J Lowe
Journal:  BMJ       Date:  2001-09-15

Review 8.  The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome.

Authors:  D A Glaser
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 9.  Evidence for effectiveness of botulinum toxin for hyperhidrosis.

Authors:  R Bhidayasiri; D D Truong
Journal:  J Neural Transm (Vienna)       Date:  2007-09-21       Impact factor: 3.575

10.  Towards a dose optimisation of botulinum toxin therapy for axillary hyperhidrosis: comparison of different Botox(®) doses.

Authors:  Dirk Dressler; Fereshte Adib Saberi
Journal:  J Neural Transm (Vienna)       Date:  2013-06-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.